However, based on the cohort used in this study, the performance of serum PSA for aggressive PCa detection dropped when serum PSA level < 20 ng/mL, whereas the urinary marker panel composed of ACPP, CLU, and/or urinary PSA showed consist performance (Fig. 3a). The gene discussed is KLK3; the disease is posterior cortical atrophy.